Skip to content
Screener

BioLife Solutions BLFS Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$28.1MBeat by $2.4M
EPS$0.04Beat by $0.04
Revenue estimate$25.7M
EPS estimate$0.00

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$29.2M
EPS estimate$0.01

Financials

Q3 2025

Income statement

See full
Revenue$28.1M+31.2%
Operating income-$89.0K+78.7%
Net income$621.0K+136%
EPS (diluted)$0.01+125%

Balance sheet

See full
Cash & equivalents$29.5M+22.0%
Total debt$20.7M-47.3%
Total equity$353.7M+8.7%
Total assets$392.1M+2.7%

Cash flow

See full
Operating cash flow$6.1M+27.1%
Free cash flow$7.6M+51.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.22B+5.8%
Enterprise value$1.21B+3.7%
P/S13.8×—

Returns & leverage

See full
Debt / equity0.1×-0.1×
Current ratio4.7×+1.9×

FAQ

When did BioLife Solutions report Q3 2025 earnings?
BioLife Solutions (BLFS) reported Q3 2025 earnings on November 6, 2025 after market close.
What were BioLife Solutions's Q3 2025 revenue and EPS?
BioLife Solutions reported revenue of $28.1M and eps of $0.04 for Q3 2025.
Did BioLife Solutions beat estimates in Q3 2025?
Revenue beat the consensus estimate of $25.7M by $2.4M. EPS beat the consensus estimate of $0.00 by $0.04.
How did BioLife Solutions's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.2% from $30.6M a year earlier.
Where can I find BioLife Solutions's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-050163) and the 10-Q periodic report (0001628280-25-050190) directly on SEC EDGAR. The filing index links above go to sec.gov.